Miramoon Pharma

Miramoon Pharma is a spin-off of the University of the Basque Country and the Biogipuzkoa Health Research Institute, developing first-in-class small molecules for complex diseases. Leveraging a proprietary chemistry platform, we target ophthalmology, muscle disorders, and CNS diseases. Our approach aims to slow disease progression, extend the therapeutic window, and unlock significant value for patients and investors.